October 04, 2024

Infant RSV Drug Plant Violated FDA Rules, Docs Show

Recent FDA documents uncover manufacturing issues at Thermo Fisher Scientific's U.S. plant, raising concerns about drug safety and regulatory compliance.

Reuters

October 03, 2024

Melania Trump Backs Abortion Rights

"Why should anyone other than the woman herself have the power to determine what she does with her own body?"

Reuters

October 03, 2024

First Emergency-Use Mpox Diagnostic Test Approved

The WHO has approved the first mpox diagnostic test for emergency use, addressing the need for effective diagnostics, particularly in low-income groups.

Reuters

September 30, 2024

Lupus Treatment Trial Paused Following Patient Deaths

Three of the fatalities showed a common pattern of symptoms and the deaths happened close to the time of dosing, while a non-fatal adverse event showed a similar proximity to dosing.

Reuters

September 30, 2024

FDA Greenlights New Heart Disease Diagnostic Drug

Clinicians have underscored Flyrcado's distinct clinical benefits such as higher-quality imaging, greater defect resolution, and improved workflow.

Reuters

September 27, 2024

FDA Approves Dupilumab for ‘Smoker's Lung'

The FDA has approved the use of dupilumab (Dupixent) for treating COPD, also known as 'smoker's lung.' The approval is anticipated to have a significant impact on the sales of the drug.

Reuters

September 26, 2024

FDA Approves Osimertinib in Stage III NSCLC After Chemoradiotherapy

The U.S. Food and Drug Administration approved osimertinib (Tagrisso) for adults with locally advanced, unresectable (stage III) non–small cell lung cancer (NSCLC) whose disease has not progressed dur...

The ASCO Post

September 25, 2024

FDA Approves IND for Liquid Botulinum Toxin Formulation

The FDA's approval of YY003 for clinical evaluation introduces a 'safer and more convenient option' with the first-ever liquid botulinum toxin in a pre-filled syringe.

Conexiant

September 24, 2024

Lupus Drug Meets Main Goal of Late-Stage Trial

Biogen and UCB's experimental lupus treatment shows promising results in reducing disease activity for lupus patients, offering hope for new therapeutic alternatives in the field.

Reuters